Form 8-K - Current report:
SEC Accession No. 0001104659-25-015897
Filing Date
2025-02-21
Accepted
2025-02-21 07:07:22
Documents
15
Period of Report
2025-02-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm257151d1_8k.htm   iXBRL 8-K 27015
2 EXHIBIT 99.1 tm257151d1_ex99-1.htm EX-99.1 90524
6 GRAPHIC tm257151d1_ex99-1img01.jpg GRAPHIC 4211
  Complete submission text file 0001104659-25-015897.txt   310310

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20250221.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20250221_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20250221_pre.xml EX-101.PRE 22373
17 EXTRACTED XBRL INSTANCE DOCUMENT tm257151d1_8k_htm.xml XML 3685
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 25648457
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)